D P Eisen

Summary

Affiliation: Royal Melbourne Hospital
Country: Australia

Publications

  1. ncbi Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates
    Jack S Richards
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Grattan St, Parkville, Victoria, 3050, Australia
    Malar J 5:55. 2006
  2. ncbi No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Hum Immunol 72:1091-4. 2011
  3. ncbi Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease
    D P Eisen
    Clinical Centre for Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Clin Exp Immunol 149:97-102. 2007
  4. ncbi Low mannose-binding lectin function is associated with sepsis in adult patients
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Vic, Australia
    FEMS Immunol Med Microbiol 48:274-82. 2006
  5. ncbi Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients
    Damon P Eisen
    Centre for Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    Med Mycol 46:371-5. 2008
  6. ncbi Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
    Damon P Eisen
    Centre for Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Clin Infect Dis 47:510-6. 2008
  7. ncbi Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals
    Damon P Eisen
    Clinical Centre for Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Malar J 6:86. 2007
  8. ncbi Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia
    Clin Infect Dis 48:e86-8. 2009
  9. ncbi Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis
    D P Eisen
    Infectious Diseases Unit, Royal Brisbane Hospital, Herston, Queensland, Australia
    Mycoses 47:159-62. 2004
  10. ncbi Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan St, Parkville, Victoria 3050, Australia
    J Infect 58:332-8. 2009

Collaborators

Detail Information

Publications26

  1. ncbi Limited polymorphism in Plasmodium falciparum ookinete surface antigen, von Willebrand factor A domain-related protein from clinical isolates
    Jack S Richards
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Grattan St, Parkville, Victoria, 3050, Australia
    Malar J 5:55. 2006
    ..In comparison to other stages of the malaria lifecycle, sexual stage antigens are under less immune selection pressure and hence are likely to have limited antigenic diversity...
  2. ncbi No association between mannose-binding lectin deficiency and H1N1 2009 infection observed during the first season of this novel pandemic influenza virus
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Hum Immunol 72:1091-4. 2011
    ..MBL appears to currently have little impact on innate immune responses to H1N1 2009 influenza...
  3. ncbi Low mannose-binding lectin complement activation function is associated with predisposition to Legionnaires' disease
    D P Eisen
    Clinical Centre for Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Clin Exp Immunol 149:97-102. 2007
    ..There was no significant interval change in MBL function or level after a mean of 46 days. MBL complement activation functional deficiency appears to predispose to Legionnaires' disease...
  4. ncbi Low mannose-binding lectin function is associated with sepsis in adult patients
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Vic, Australia
    FEMS Immunol Med Microbiol 48:274-82. 2006
    ..Deficiency of MBL function appears to be associated with bloodstream infection and the development of septic shock. High MBL levels may be protective against severe sepsis...
  5. ncbi Mannose-binding lectin deficiency does not appear to predispose to cryptococcosis in non-immunocompromised patients
    Damon P Eisen
    Centre for Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Victoria, Australia
    Med Mycol 46:371-5. 2008
    ..It appears that MBL deficiency is not associated with cryptococcosis in non-immunocompromised hosts. Beta errors consequent on the small number of patients studied may account for the lack of association...
  6. ncbi Low serum mannose-binding lectin level increases the risk of death due to pneumococcal infection
    Damon P Eisen
    Centre for Clinical Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Clin Infect Dis 47:510-6. 2008
    ..However, MBL deficiency has not been rigorously defined, and associations with sepsis outcomes have not been subjected to multivariable analysis...
  7. ncbi Antibodies elicited in adults by a primary Plasmodium falciparum blood-stage infection recognize different epitopes compared with immune individuals
    Damon P Eisen
    Clinical Centre for Research Excellence in Infectious Diseases, Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Victoria, Australia
    Malar J 6:86. 2007
    ....
  8. ncbi Decreased viral load and symptoms of polyomavirus-associated chronic interstitial cystitis after intravesical cidofovir treatment
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Australia
    Clin Infect Dis 48:e86-8. 2009
    ..Another patient had milder symptoms of cystitis and intermittent polyomavirus shedding. Polyomaviruses, particularly BK virus, may cause some cases of interstitial cystitis...
  9. ncbi Complete resolution of pulmonary Rhizopus oryzae infection with itraconazole treatment: more evidence of the utility of azoles for zygomycosis
    D P Eisen
    Infectious Diseases Unit, Royal Brisbane Hospital, Herston, Queensland, Australia
    Mycoses 47:159-62. 2004
    ..This patient was cured through the use of itraconazole alone and the literature on the utility of azole antifungals for zygomycosis is reviewed...
  10. ncbi Reduced valve replacement surgery and complication rate in Staphylococcus aureus endocarditis patients receiving acetyl-salicylic acid
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Grattan St, Parkville, Victoria 3050, Australia
    J Infect 58:332-8. 2009
    ..To assess the influence of acetyl-salicylic acid (ASA) on clinical outcomes in Staphylococcus aureus infective endocarditis (SA-IE)...
  11. ncbi Mannose-binding lectin deficiency and respiratory tract infection
    Damon P Eisen
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Vic, Australia
    J Innate Immun 2:114-22. 2010
    ..The available literature suggests that it may also be of benefit in MBL deficient patients with severe pneumonia. This review concentrates on clinical associations between MBL deficiency and susceptibility to respiratory tract infection...
  12. ncbi Impact of mannose-binding lectin on susceptibility to infectious diseases
    Damon P Eisen
    Infectious Diseases Unit, Royal Brisbane Hospital, Herston, Queensland, Australia
    Clin Infect Dis 37:1496-505. 2003
    ..Numerous other potential infectious disease associations have been described. Therapy to supplement low MBL levels is being explored using either plasma-derived or recombinant material...
  13. ncbi Tropical pulmonary eosinophilia: a rare cause of cough in immigrants to Australia
    Michelle K Yong
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Med J Aust 187:416-8. 2007
  14. ncbi Mannose-binding lectin and susceptibility to tuberculosis: a meta-analysis
    J T Denholm
    Victorian Infectious Diseases Service, Royal Melbourne Hospital, Parkville, Melbourne, Vic, Australia
    Clin Exp Immunol 162:84-90. 2010
    ..This analysis suggests that the relatively poorly characterized MBL2 genotypes reported are not associated significantly with susceptibility to pulmonary TB infection, but high MBL serum levels may be...
  15. ncbi Donor mannose-binding lectin deficiency increases the likelihood of clinically significant infection after liver transplantation
    Daniel L Worthley
    RBWH Foundation Clinical Research Centre, Royal Brisbane and Women s Hospital and Queensland Institute of Medical Research, Brisbane, Queensland, Australia
    Clin Infect Dis 48:410-7. 2009
    ..We report a large, retrospective study that examined the association between MBL status and clinically significant infection following orthotopic liver transplantation...
  16. ncbi Antibody recognition of heterologous variant surface antigens after a single Plasmodium falciparum infection in previously naive adults
    Salenna R Elliott
    Department of Medicine, The University of Melbourne, Royal Melbourne Hospital, Victoria, Australia
    Am J Trop Med Hyg 76:860-4. 2007
    ..Together these data suggest that a single P. falciparum infection can be sufficient to induce antibodies reactive with several PfEMP1 variants, although the repertoire of target epitopes they recognize may still be restricted...
  17. ncbi Alterations in Plasmodium falciparum genotypes during sequential infections suggest the presence of strain specific immunity
    Damon P Eisen
    Department of Microbiology, Monash University, Clayton, Victoria, Australia
    Am J Trop Med Hyg 67:8-16. 2002
    ..This strain was predominant at the first time point but had disappeared at the fourth time point. This significant change in malaria genotypes could be due to strain-specific immunity developing in this population...
  18. ncbi Personal protective equipment and antiviral drug use during hospitalization for suspected avian or pandemic influenza
    Ashwin Swaminathan
    Austin Health, Melbourne, Victoria, Australia
    Emerg Infect Dis 13:1541-7. 2007
    ..Up to 41% of HCW close contacts would have qualified for postexposure antiviral prophylaxis. These data indicate that many current national stockpiles of PPE and antiviral medication are likely inadequate for a pandemic...
  19. ncbi The body as fortress: innate immune surveillance
    R M Minchinton
    Australian Red Cross Blood Service, Post Office Box 10325 Adelaide Street, Brisbane, Queensland, Australia
    Vox Sang 87:30-4. 2004
  20. ncbi Increase in prevalence of nosocomial non-Candida albicans candidaemia and the association of Candida krusei with fluconazole use
    W Hope
    Infectious Diseases Unit, Royal Brisbane Hospital, Brisbane, Queensland, Australia
    J Hosp Infect 50:56-65. 2002
    ..78, P<0.001). There was no evidence of spread of C. krusei using random amplification of polymorphic DNA, suggesting the appearance of this organism was due to the selection pressure exerted by fluconazole...
  21. ncbi Mannose binding lectin acute phase activity in patients with severe infection
    M M Dean
    Co operative Research Centre for Vaccine Technology, Australian Red Cross Blood Service, Adelaide St, Brisbane, Queensland, Australia
    J Clin Immunol 25:346-52. 2005
    ..These findings indicate MBL demonstrates a variable acute phase response in the clinical setting of sepsis and septic shock...
  22. ncbi Characterization of the antibody response against Plasmodium falciparum erythrocyte membrane protein 1 in human volunteers
    Darren R Krause
    Malaria Drug Resistance and Chemotherapy, Infectious Diseases and Immunology Division, The Queensland Institute of Medical Research, Post Office Royal Brisbane Hospital, QLD 4029, Australia
    Infect Immun 75:5967-73. 2007
    ..falciparum suggests that the anti-PfEMP1 antibodies often persisted for more than 100 days after a single infection. These results help to further our understanding of the development of acquired immunity to P. falciparum infections...
  23. ncbi Cryptococcal dementia in a patient with sarcoidosis
    Siddhartha Deb
    Melbourne Neuropsychiatry Centre, Royal Melbourne Hospital, Melbourne, Vic, Australia
    Med J Aust 184:86-7. 2006
  24. ncbi An outbreak of Plasmodium vivax malaria in Far North Queensland, 2002
    Jeffrey N Hanna
    Tropical Public Health Unit, Queensland Health, PO Box 1103, Cairns, QLD 4870, Australia
    Med J Aust 180:24-8. 2004
    ..To describe an outbreak of Plasmodium vivax malaria in Far North Queensland in 2002...
  25. ncbi Immunity to malaria after administration of ultra-low doses of red cells infected with Plasmodium falciparum
    David J Pombo
    Queensland Institute of Medical Research, Australian Centre for International and Tropical Health and Nutrition, and Cooperative Research Centre for Vaccine Technology, PO Royal Brisbane Hospital, Australia
    Lancet 360:610-7. 2002
    ..People can be protected against the erythrocytic stage of malaria by a strong cell-mediated immune response, in the absence of detectable parasite-specific antibodies, suggesting an additional strategy for development of a malaria vaccine..
  26. ncbi A human phase 1 vaccine clinical trial of the Plasmodium falciparum malaria vaccine candidate apical membrane antigen 1 in Montanide ISA720 adjuvant
    Allan Saul
    The Cooperative Research Centre for Vaccine Technology, Brisbane, QLD, Australia
    Vaccine 23:3076-83. 2005
    ..Six of the 29 subjects seroconverted. Only one of these developed a high antibody titre. However, the interpretation of this trial was compromised by a loss of potency of the formulated vaccine during the course of the study...